£87.00

Südwestdeutscher Verlag für Hochschulschriften Die kombinierte targeted Therapie beim Prostatakarzinom: Molekulare Analysen zum Einfluss der kombinierten targeted Therapie beim Prostatakarzinom in-vitro und in-vivo

Price data last checked 60 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 31 days • 31 data points (No recent data available)

Historical
Generating forecast...
£87.00 £82.65 £84.39 £86.13 £87.87 £89.61 £91.35 30 January 2026 06 February 2026 14 February 2026 21 February 2026 01 March 2026

Price Distribution

Price distribution over 31 days • 1 price levels

Days at Price
31 days 0 8 16 23 31 £87 Days at Price

Price Analysis

Most common price: £87 (31 days, 100.0%)

Price range: £87 - £87

Price levels: 1 different prices over 31 days

Description

Das Prostatakarzinom (PCa) gehört weltweit zu den häufigsten bösartigen Malignitäten beim Mann. Ist das hormonrefraktäre Stadium erreicht, stehen nur begrenzte Therapieoptionen zur Verfügung. In der jüngeren Vergangenheit wurden neue molekulare Substanzen entwickelt, die gezielt in den Metabolismus der Karzinomzellen eingreifen, die targeted therapy molecules. Das Verständnis des Zusammenspiels von parallelen und interagierenden mitogenen Signaltransduktionswegen beim PCa, die sein Wachstum, seine Differenzierung und seine Zellmotiliät regulieren, ist von enormer Bedeutung, um neue bzw. schon bestehende Inhibitoren gegen PCa erfolgreich zu entwickeln oder als Mono- bzw. Kombinationstherapie anzuwenden. Zu den beim PCa häufig überexprimierten Signalproteinen gehören der mammalian target of rapamycin, die Rezeptor-Tyrosinkinasen und die Histondeacetylasen. Ziel dieser Arbeit war es, die Effektivität von Inhibitoren auf diese Signalproteine als Einzel- und Kombinationstherapie im Hinblick auf das Zellwachstum und die Adhäsionseigenschaft der PCa-Zellen zu untersuchen. Zur Anwendung kamen RAD001, AEE788, die Valproinsäure und das Interferon-α-2a, ein körpereigenes Zytokin.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
27 July 2011
Listed Since
28 July 2011

Barcode

No barcode data available

Similar Products You Might Like

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)
96% match

Improving the Therapeutic Ratio in Head and Neck Cancer (Volume 6) (Cancer Sensitizing Agents for Chemotherapy, Volume 6)

Academic Press

£111.19 10 Mar 2026
Springer - Molecular Mechanisms of Tumor Cell Resistance
96% match

Springer - Molecular Mechanisms of Tumor Cell Resistance

Springer

£93.87 19 Apr 2026
Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)
96% match

Genes, Oncogenes, and Hormones: Advances in Cellular and Molecular Biology of Breast Cancer: 61 (Cancer Treatment and Research, 61)

Springer

£201.60 11 Jan 2026
Springer Cancer Chemotherapy Volume 36 - Research Series
96% match

Springer Cancer Chemotherapy Volume 36 - Research Series

Springer

£113.25 05 Mar 2026
Advances in Cancer Signal Transduction and Therapy
96% match

Advances in Cancer Signal Transduction and Therapy

Bentham Science Publishers

£82.52 09 Apr 2026
Springer Molecular Basis of Human Cancer - NATO Science Series
96% match

Springer Molecular Basis of Human Cancer - NATO Science Series

Springer

£121.37 24 Feb 2026
Targeted Therapies in Oncology
96% match

Targeted Therapies in Oncology

CRC Press

£105.94 25 Feb 2026
Prognostic and Therapeutic Applications of RKIP in Cancer
96% match

Prognostic and Therapeutic Applications of RKIP in Cancer

Academic Press

£96.59 09 Mar 2026
Advances in Cancer Research: 77: Volume 77
96% match

Advances in Cancer Research: 77: Volume 77

Academic Press

£90.19 08 Mar 2026
Genitourinary Cancer: Basic and Clinical Aspects: 34 (Cancer Treatment and Research, 34)
96% match

Genitourinary Cancer: Basic and Clinical Aspects: 34 (Cancer Treatment and Research, 34)

Springer

£165.78 24 Jan 2026
Molecular Oncology: Underlying Mechanisms and Translational Advancements
96% match

Molecular Oncology: Underlying Mechanisms and Translational Advancements

Springer

£82.73 09 Mar 2026
Cancer Biology and Therapeutics
95% match

Cancer Biology and Therapeutics

Springer

£165.87 02 Mar 2026
Melanoma Research: Genetics, Growth Factors, Metastases, and Antigens: 54 (Cancer Treatment and Research, 54)
95% match

Melanoma Research: Genetics, Growth Factors, Metastases, and Antigens: 54 (Cancer Treatment and Research, 54)

Springer

£104.20 12 Jan 2026
Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)
95% match

Concepts, Mechanisms, and New Targets for Chemotherapy: 78 (Cancer Treatment and Research, 78)

Springer

£149.64 19 Apr 2026
Cancer Biology and Therapeutics
95% match

Cancer Biology and Therapeutics

Springer

£148.77 13 Jan 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)
95% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression, 9)

Springer

£174.97 28 Mar 2026
Cancer Chemotherapy 1: Cancer Treatment and Research: 7
95% match

Cancer Chemotherapy 1: Cancer Treatment and Research: 7

Springer

£166.09 09 Apr 2026
Elsevier Advances in Oncology, 2022 (Volume 2-1) Medical Book
95% match

Elsevier Advances in Oncology, 2022 (Volume 2-1) Medical Book

Elsevier

£126.38 04 Mar 2026
Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)
95% match

Handbook of Research on Advancements in Cancer Therapeutics (Advances in Medical Diagnosis, Treatment, and Care)

£418.38 11 Jan 2026
Springer Advances in Molecular Oncology: 604 - Science Book
95% match

Springer Advances in Molecular Oncology: 604 - Science Book

Springer

£105.11 24 Feb 2026
Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)
95% match

Tumor Immune Microenvironment in Cancer Progression and Cancer Therapy: 1036 (Advances in Experimental Medicine and Biology, 1036)

Springer

£125.98 11 Jan 2026
Oncogenes: 47 (Cancer Treatment and Research, 47)
95% match

Oncogenes: 47 (Cancer Treatment and Research, 47)

Springer

£148.77 25 Jan 2026
Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)
95% match

Cancer Management in Man: Detection, Diagnosis, Surgery, Radiology, Chronobiology, Endocrine Therapy: 9 (Cancer Growth and Progression)

Springer

£175.38 08 Apr 2026
Management of Advanced Prostate Cancer
95% match

Management of Advanced Prostate Cancer

Springer

£81.44 08 Mar 2026